ACXP vs. GDE
ACXP (Acurx Pharmaceuticals, Inc.) is a stock, while GDE (WisdomTree Efficient Gold Plus Equity Strategy Fund) is Gold fund actively managed by WisdomTree. Over the past 3 years, ACXP returned -69.77%/yr vs 40.84%/yr for GDE. At a 0.14 correlation, their price movements are largely independent.
Performance
ACXP vs. GDE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ACXP achieves a -42.97% return, which is significantly lower than GDE's -0.50% return.
ACXP
- 1D
- -5.96%
- 1M
- -27.92%
- YTD
- -42.97%
- 6M
- -59.43%
- 1Y
- -88.22%
- 3Y*
- -69.77%
- 5Y*
- —
- 10Y*
- —
GDE
- 1D
- -3.14%
- 1M
- -10.04%
- YTD
- -0.50%
- 6M
- -5.03%
- 1Y
- 37.19%
- 3Y*
- 40.84%
- 5Y*
- —
- 10Y*
- —
ACXP vs. GDE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
ACXP Acurx Pharmaceuticals, Inc. | -42.97% | -84.71% | -78.75% | -3.77% | 6.99% |
GDE WisdomTree Efficient Gold Plus Equity Strategy Fund | -0.50% | 73.76% | 44.79% | 33.85% | -8.58% |
Correlation
The correlation between ACXP and GDE is 0.15, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.15 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.15 |
Correlation (All Time) Calculated using the full available price history since Mar 17, 2022 | 0.14 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ACXP vs. GDE — Risk / Return Rank
ACXP
GDE
ACXP vs. GDE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Acurx Pharmaceuticals, Inc. (ACXP) and WisdomTree Efficient Gold Plus Equity Strategy Fund (GDE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ACXP | GDE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.70 | ||
| Sortino ratioReturn per unit of downside risk | -2.67 | ||
| Omega ratioGain probability vs. loss probability | 0.90 | 1.24 | -0.34 |
| Calmar ratioReturn relative to maximum drawdown | -0.99 | 1.65 | -2.64 |
| Martin ratioReturn relative to average drawdown | -1.27 | 4.59 | -5.86 |
Loading charts...
Drawdowns
ACXP vs. GDE - Drawdown Comparison
The maximum ACXP drawdown since its inception was -99.14%, which is greater than GDE's maximum drawdown of -32.01%. Use the drawdown chart below to compare losses from any high point for ACXP and GDE.
Loading charts...
Drawdown Indicators
| ACXP | GDE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.14% | -32.01% | -67.13% |
Max Drawdown (1Y)Largest decline over 1 year | -89.26% | -22.66% | -66.60% |
Max Drawdown (3Y)Largest decline over 3 years | -98.83% | -22.66% | -76.17% |
Max Drawdown (5Y)Largest decline over 5 years | -99.14% | — | — |
Current DrawdownCurrent decline from peak | -99.10% | -19.50% | -79.60% |
Average DrawdownAverage peak-to-trough decline | -69.53% | -7.97% | -61.56% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 69.38% | 8.12% | +61.26% |
Volatility
ACXP vs. GDE - Volatility Comparison
Acurx Pharmaceuticals, Inc. (ACXP) has a higher volatility of 12.70% compared to WisdomTree Efficient Gold Plus Equity Strategy Fund (GDE) at 11.41%. This indicates that ACXP's price experiences larger fluctuations and is considered to be riskier than GDE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ACXP | GDE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 12.70% | 11.41% | +1.29% |
Volatility (6M)Calculated over the trailing 6-month period | 119.86% | 26.51% | +93.35% |
Volatility (1Y)Calculated over the trailing 1-year period | 188.28% | 30.33% | +157.95% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 140.89% | 27.15% | +113.74% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 140.89% | 27.15% | +113.74% |
Dividends
ACXP vs. GDE - Dividend Comparison
ACXP has not paid dividends to shareholders, while GDE's dividend yield for the trailing twelve months is around 4.34%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
ACXP Acurx Pharmaceuticals, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
GDE WisdomTree Efficient Gold Plus Equity Strategy Fund | 4.34% | 4.32% | 7.14% | 2.22% | 0.81% |
Frequently Asked Questions
ACXP and GDE have a correlation of 0.15, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ACXP has higher volatility (12.70%) compared to GDE (11.41%). In terms of maximum drawdown, ACXP dropped -99.14% vs GDE's -32.01%.
GDE currently has the higher Sharpe Ratio (1.23 vs -0.47), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ACXP and GDE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer